北美有源医疗植入设备市场，按产品（心脏再同步治疗设备 (CRT-D)、植入式心律转复除颤器、植入式心脏起搏器、眼部植入物、神经刺激器、有源植入式听力设备、心室辅助设备、植入式心脏监护仪/可插入式循环记录器、近距离放射治疗、植入式血糖监测仪、下垂足部植入物、肩部植入物、植入式输液泵和植入式配件）、手术类型（传统手术方法和微创手术）、程序（神经血管、心血管、听力等）、最终用户（医院、专科诊所、门诊手术中心、诊所）、国家（美国、加拿大、墨西哥）行业趋势和预测到 2028 年
市场分析与洞察：北美有源医疗植入设备市场
北美有源医疗植入设备市场预计将在 2021 年至 2028 年的预测期内实现显着增长。Data Bridge Market Research 分析称，在 2021 年至 2028 年的预测期内，该市场以 7.9% 的复合年增长率增长，预计到 2028 年将达到 126.6568 亿美元。医疗保健行业研发活动的增加和医疗保健支出的增加是预测期内推动市场增长的主要驱动力。政府资金和投资的增加为公司推出更多产品提供了机会。然而，植入设备的高成本和产品召回是市场面临的主要挑战。
有源植入式医疗设备是通过外科手术插入患者体内的动力设备，并且在手术后仍留在患者体内。
技术的不断进步推动了北美有源医疗植入设备市场的增长。各大地区对新产品开发活动的投资不断增加，预计将在未来几年推动有源医疗植入设备的需求。而治疗的成本和有害影响阻碍了市场的增长。
北美有源医疗植入设备市场报告提供了市场份额、新发展和产品线分析、国内和本地市场参与者的影响的详细信息，分析了新兴收入领域、市场法规变化、产品审批、战略决策、产品发布、地域扩张和市场技术创新方面的机会。要了解分析和市场情况，请联系我们获取分析师简报，我们的团队将帮助您创建收入影响解决方案，以实现您的预期目标。
北美有源医疗植入设备市场范围和市场规模
北美有源医疗植入设备市场根据产品、手术类型、程序和最终用户进行细分。细分市场之间的增长有助于您分析利基增长领域和进入市场的策略，并确定您的核心应用领域和目标市场的差异。
- 根据产品，北美有源医疗植入设备市场细分为心脏再同步治疗设备 (CRT-D)、植入式心律转复除颤器、植入式心脏起搏器、眼部植入物、神经刺激器、有源植入式听力设备、心室辅助设备、植入式心脏监测器/植入式循环记录器、近距离放射治疗、植入式血糖监测器、足下植入物、肩部植入物、植入式输液泵和植入式配件。2021 年，心脏再同步治疗设备 (CRT-D) 细分市场预计将占据市场主导地位，因为其高效的效果将推动对植入式设备的需求增加。
- 根据手术类型，北美有源医疗植入设备市场分为传统手术方法和微创手术。 2021 年，传统手术方法部分预计将占据市场主导地位，因为它具有合理的治疗成本和费用。
- 根据程序，北美有源医疗植入设备市场细分为神经血管、心血管、听力和其他。2021 年，随着心血管疾病的增加，心血管预计将占据市场主导地位。
- 根据最终用户，北美有源医疗植入设备市场分为医院、专科诊所、门诊手术中心和诊所。由于有源医疗植入设备的需求不断增长，预计 2021 年医院部门将占据市场主导地位
北美有源医疗植入设备市场国家级分析
对北美有源医疗植入设备市场进行分析，并根据产品、手术类型、程序、最终用户提供市场规模信息。
有源医疗植入设备市场报告涵盖的国家包括美国、加拿大和墨西哥。
由于为提高产品质量而不断增加的研究开发，预计北美地区的有源医疗植入设备市场将在 2021 年至 2028 年的预测期内以最高增长率增长。美国引领北美有源医疗植入设备市场的增长，并且由于该国疾病患病率不断上升，心血管领域在该国占据主导地位。
报告的国家部分还提供了影响单个市场因素和国内市场监管变化，这些因素和变化会影响市场的当前和未来趋势。新销售、替代销售、国家人口统计、监管法案和进出口关税等数据点是用于预测单个国家市场情景的一些主要指标。此外，在提供国家数据的预测分析时，还考虑了北美品牌的存在和可用性以及由于来自本地和国内品牌的激烈或稀少的竞争而面临的挑战、销售渠道的影响。
新产品开发的进步和技术的提高正在推动有源医疗植入设备市场的增长
北美有源医疗植入设备市场还为您提供每个国家有源医疗植入设备行业增长的详细市场分析，包括有源医疗植入设备药品销售、有源医疗植入设备技术进步的影响以及监管环境的变化及其对市场的支持。数据涵盖 2010 年至 2018 年的历史时期。
竞争格局和有源医疗植入设备市场份额分析
有源医疗植入设备市场竞争格局按竞争对手提供详细信息。详细信息包括公司概况、公司财务状况、收入、市场潜力、研发投资、新市场计划、生产基地和设施、公司优势和劣势、产品发布、产品试验渠道、产品批准、专利、产品宽度和广度、应用主导地位、技术生命线曲线。以上提供的数据点仅与公司对有源医疗植入设备市场的关注有关。
在北美有源医疗植入式设备市场开展业务的主要公司有 NeuroPace, Inc.、Axonics, Inc.、Stimwave LLC、NEVRO CORP、Second Sight、BIOTRONIK、ABIOMED、Boston Scientific Corporation、Medtronic、Abbott、Eckert & Ziegler.、Sonova、浙江诺尔康生物技术有限公司、Demant A/S、Cochlear Ltd、Microson、Oticon Medical、Nano Retina、GluSense、MED-EL Medical Electronics 等。
全球各地的公司还发起了多项产品发布和协议，这也加速了有源医疗植入设备市场的增长。
例如，
- 2021 年 3 月，Medline industries, Inc 宣布他们已获得一份主要供应商合同，成为 Windsor Lane Health Care 的独家供应供应商，Windsor Lane Health Care 是一家位于俄亥俄州的长期护理机构，已在美国扩大了其供应链。
- 2020 年 1 月，Medline Industries, Inc. 宣布收购魁北克市的医疗和牙科用品分销商 Médi-Sélect，加入其 Medline Canada 业务，从而扩大了其分销和供应链网络
SKU-
Get online access to the report on the World's First Market Intelligence Cloud
- Interactive Data Analysis Dashboard
- Company Analysis Dashboard for high growth potential opportunities
- Research Analyst Access for customization & queries
- Competitor Analysis with Interactive dashboard
- Latest News, Updates & Trend analysis
- Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
目录
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF NORTH AMERICA ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET
1.4 LIMITATIONS
1.5 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 CURRENCY AND PRICING
2.5 DBMR TRIPOD DATA VALIDATION MODEL
2.6 MULTIVARIATE MODELLING
2.7 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.8 DBMR MARKET POSITION GRID
2.9 MARKET APPLICATION COVERAGE GRID
2.1 VENDOR SHARE ANALYSIS
2.11 SECONDARY SOURCES
2.12 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 INDUSTRY INSIGHTS
5 REGULATORY ANALYSIS
5.1 REGULATION IN EUROPE
5.2 REGULATION IN U.S.
5.3 REGULATION IN CANADA
5.4 REGULATION IN CHINA
6 MARKET OVERVIEW
6.1 DRIVERS
6.1.1 TECHNOLOGICAL ADVANCEMENT
6.1.2 INCREASING BURDEN OF CARDIOVASCULAR DISEASES, NEUROLOGICAL DISORDERS AND HEARING DISORDERS
6.1.3 INCREASING FDA APPROVAL
6.1.4 RISING AWARENESS FOR MEDICAL IMPLANTS
6.2 RESTRAINTS
6.2.1 HIGH COST OF MEDICAL IMPLANTS
6.2.2 INCREASING RISK OF DEVELOPING INFECTION AND OTHER COMPLICATIONS
6.3 OPPORTUNITIES
6.3.1 INCREASE IN DEMAND FOR MINIMALLY INVASIVE SURGERIES
6.3.2 STRATEGIC INITIATIVES BY KEY MARKET PLAYERS
6.3.3 INCREASE IN THE GERIATRIC POPULATION
6.3.4 RISING HEALTHCARE INFRASTRUCTURE
6.4 CHALLENGES
6.4.1 INCREASING PRODUCT RECALL
6.4.2 SUPPLY CHAIN DISRUPTION DUT TO COVID-19 PANDEMIC OUTBREAK
7 IMPACT OF COVID-19
7.1 IMPACT ON PRICE
7.2 IMPACT ON DEMAND
7.3 IMPACT ON SUPPLY
7.4 STRATEGIC DECISIONS OF GOVERNMENT AND MANUFACTURERS
7.5 CONCLUSION
8 NORTH AMERICA ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET, BY PRODUCT
8.1 OVERVIEW
8.2 CARDIAC RESYNCHRONIZATION THERAPY DEVICES (CRT-D)
8.3 IMPLANTABLE CARDIOVERTER DEFIBRILLATORS
8.3.1 TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS
8.3.1.1 DUAL-CHAMBER IMPLANTABLE CARDIOVERTER DEFIBRILLATORS
8.3.1.2 BIVENTRICULAR IMPLANTABLE CARDIOVERTER DEFIBRILLATORS (ICDS)/ CARDIAC RESYNCHRONIZATION THERAPY DEFIBRILLATORS (CRT-DS)
8.3.1.3 SINGLE-CHAMBER IMPLANTABLE CARDIOVERTER DEFIBRILLATORS
8.3.2 SUBCUTANEOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS
8.4 IMPLANTABLE CARDIAC PACEMAKERS
8.4.1 DUAL CHAMBER PACEMAKERS
8.4.2 BIVENTRICULAR PACEMAKERS
8.4.3 SINGLE CHAMBER PACEMAKERS
8.5 EYE IMPLANTS
8.6 NEUROSTIMULATORS
8.6.1 SPINAL CORD STIMULATORS
8.6.2 DEEP BRAIN STIMULATORS
8.6.3 BLADDER STIMULATORS
8.6.4 GASTRIC NERVE STIMULATORS
8.6.5 SACRAL NERVE STIMULATORS
8.6.6 LIMB FUNCTION STIMULATORS
8.6.7 VAGUS STIMULATORS
8.6.8 OTHERS
8.7 ACTIVE IMPLANTABLE HEARING DEVICES
8.8 VENTRICULAR ASSIST DEVICES
8.9 IMPLANTABLE HEART MONITORS/ INSERTABLE LOOP RECORDERS
8.1 BRACHYTHERAPY
8.11 IMPLANTABLE GLUCOSE MONITORS
8.12 DROPPED FOOT IMPLANTS
8.13 SHOULDER IMPLANTS
8.14 IMPLANTABLE INFUSION PUMPS
8.15 IMPLANTABLE ACCESSORIES
8.15.1 LEAD
8.15.2 ELECTRODES
8.15.3 ADAPTORS
8.15.4 OTHERS
9 NORTH AMERICA ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET, BY SURGERY TYPE
9.1 OVERVIEW
9.2 TRADITIONAL SURGICAL METHODS
9.3 MINIMALLY INVASIVE SURGERY
10 NORTH AMERICA ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET, BY PROCEDURE
10.1 OVERVIEW
10.2 CARDIOVASCULAR
10.3 NEUROLOGICAL
10.4 HEARING
10.5 OTHERS
11 NORTH AMERICA ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET, BY END USER
11.1 OVERVIEW
11.2 HOSPITALS
11.3 AMBULATORY SURGICAL CENTERS
11.4 SPECIALIZED CLINICS
11.5 CLINICS
12 NORTH AMERICA ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET, BY REGION
12.1 NORTH AMERICA
12.1.1 U.S.
12.1.2 CANADA
12.1.3 MEXICO
13 NORTH AMERICA ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET: COMPANY LANDSCAPE
13.1 COMPANY SHARE ANALYSIS: NORTH AMERICA
14 COMPANY PROFILE
14.1 MEDTRONIC
14.1.1 COMPANY SNAPSHOT
14.1.2 REVENUE ANALYSIS
14.1.3 COMPANY SHARE ANALYSIS
14.1.4 PRODUCT PORTFOLIO
14.1.5 RECENT DEVELOPMENTS
14.2 ABBOTT
14.2.1 COMPANY SNAPSHOT
14.2.2 REVENUE ANALYSIS
14.2.3 COMPANY SHARE ANALYSIS
14.2.4 PRODUCT PORTFOLIO
14.2.5 RECENT DEVELOPMENTS
14.3 BOSTON SCIENTIFIC CORPORATION
14.3.1 COMPANY SNAPSHOT
14.3.2 REVENUE ANALYSIS
14.3.3 COMPANY SHARE ANALYSIS
14.3.4 PRODUCT PORTFOLIO
14.3.5 RECENT DEVELOPMENTS
14.4 COCHLEAR LTD
14.4.1 COMPANY SNAPSHOT
14.4.2 REVENUE ANALYSIS
14.4.3 COMPANY SHARE ANALYSIS
14.4.4 PRODUCT PORTFOLIO
14.4.5 RECENT DEVELOPMENT
14.5 ABIOMED
14.5.1 COMPANY SNAPSHOT
14.5.2 REVENUE ANALYSIS
14.5.3 COMPANY SHARE ANALYSIS
14.5.4 PRODUCT PORTFOLIO
14.5.5 RECENT DEVELOPMENTS
14.6 AXONICS, INC.
14.6.1 COMPANY SNAPSHOT
14.6.2 REVENUE ANALYSIS
14.6.3 PRODUCT PORTFOLIO
14.6.4 RECENT DEVELOPMENTS
14.7 BIOTRONIK SE & CO. KG
14.7.1 COMPANY SNAPSHOT
14.7.2 PRODUCT PORTFOLIO
14.7.3 RECENT DEVELOPMENTS
14.8 DEMANT A/S
14.8.1 COMPANY SNAPSHOT
14.8.2 REVENUE ANALYSIS
14.8.3 PRODUCT PORTFOLIO
14.8.4 RECENT DEVELOPMENT
14.9 ECKERT & ZIEGLER.
14.9.1 COMPANY SNAPSHOT
14.9.2 REVENUE ANALYSIS
14.9.3 PRODUCT PORTFOLIO
14.9.4 RECENT DEVELOPMENTS
14.1 GLUSENSE
14.10.1 COMPANY SNAPSHOT
14.10.2 PRODUCT PORTFOLIO
14.10.3 RECENT DEVELOPMENTS
14.11 MED-EL MEDICAL ELECTRONICS
14.11.1 COMPANY SNAPSHOT
14.11.2 PRODUCT PORTFOLIO
14.11.3 RECENT DEVELOPMENTS
14.12 MICROSON
14.12.1 COMPANY SNAPSHOT
14.12.2 PRODUCT PORTFOLIO
14.12.3 RECENT DEVELOPMENTS
14.13 NANO RETINA
14.13.1 COMPANY SNAPSHOT
14.13.2 PRODUCT PORTFOLIO
14.13.3 RECENT DEVELOPMENT
14.14 NEUROPACE, INC.
14.14.1 COMPANY SNAPSHOT
14.14.2 REVENUE ANALYSIS
14.14.3 PRODUCT PORTFOLIO
14.14.4 RECENT DEVELOPMENT
14.15 NEVRO CORP.
14.15.1 COMPANY SNAPSHOT
14.15.2 REVENUE ANALYSIS
14.15.3 PRODUCT PORTFOLIO
14.15.4 RECENT DEVELOPMENTS
14.15.5 RECENT DEVELOPMENTS
14.16 OTICON MEDICAL
14.16.1 COMPANY SNAPSHOT
14.16.2 PRODUCT PORTFOLIO
14.16.3 RECENT DEVELOPMENTS
14.17 SECOND SIGHT
14.17.1 COMPANY SNAPSHOT
14.17.2 PRODUCT PORTFOLIO
14.17.3 RECENT DEVELOPMENT
14.18 SONOVA
14.18.1 COMPANY SNAPSHOT
14.18.2 REVENUE ANALYSIS
14.18.3 PRODUCT PORTFOLIO
14.18.4 RECENT DEVELOPMENTS
14.19 STIMWAVE LLC
14.19.1 COMPANY SNAPSHOT
14.19.2 PRODUCT PORTFOLIO
14.19.3 RECENT DEVELOPMENT
14.2 ZHEJIANG NUROTRON BIOTECHNOLOGY CO., LTD
14.20.1 COMPANY SNAPSHOT
14.20.2 PRODUCT PORTFOLIO
14.20.3 RECENT DEVELOPMENT
15 QUESTIONNAIRE
16 RELATED REPORTS
表格列表
TABLE 1 NORTH AMERICA ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET, BY PRODUCT, 2019-2028 (USD MILLION)
TABLE 2 NORTH AMERICA CARDIAC RESYNCHRONIZATION THERAPY DEVICES (CRT-D) IN ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 3 NORTH AMERICA IMPLANTABLE CARDIOVERTER DEFIBRILLATORS IN ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 4 NORTH AMERICA IMPLANTABLE CARDIOVERTER DEFIBRILLATORS IN ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET, BY PRODUCT, 2019-2028 (USD MILLION)
TABLE 5 NORTH AMERICA TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS IN ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET, BY PRODUCT, 2019-2028 (USD MILLION)
TABLE 6 NORTH AMERICA IMPLANTABLE CARDIAC PACEMAKERS IN ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 7 NORTH AMERICA IMPLANTABLE CARDIAC PACEMAKERS IN ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET, BY PRODUCT, 2019-2028 (USD MILLION)
TABLE 8 NORTH AMERICA EYE IMPLANTS IN ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 9 NORTH AMERICA NEUROSTIMULATORS IN ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 10 NORTH AMERICA NEUROSTIMULATORS IN ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET, BY PRODUCT, 2019-2028 (USD MILLION)
TABLE 11 NORTH AMERICA ACTIVE IMPLANTABLE HEARING DEVICES IN ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 12 NORTH AMERICA VENTRICULAR ASSIST DEVICES IN ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 13 NORTH AMERICA IMPLANTABLE HEART MONITORS/ INSERTABLE LOOP RECORDERS IN ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 14 NORTH AMERICA BRACHYTHERAPY IN ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 15 NORTH AMERICA IMPLANTABLE GLUCOSE MONITORS IN ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 16 NORTH AMERICA DROPPED FOOT IMPLANTS IN ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 17 NORTH AMERICA SHOULDER IMPLANTS IN ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 18 NORTH AMERICA IMPLANTABLE INFUSION PUMPS IN ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 19 NORTH AMERICA IMPLANTABLE ACCESSORIES IN ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 20 NORTH AMERICA IMPLANTABLE ACCESSORIES IN ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET, BY PRODUCT, 2019-2028 (USD MILLION)
TABLE 21 NORTH AMERICA ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET, BY SURGERY TYPE, 2019-2028 (USD MILLION)
TABLE 22 NORTH AMERICA TRADITIONAL SURGICAL METHODS IN ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 23 NORTH AMERICA MINIMALLY INVASIVE SURGERY IN ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 24 NORTH AMERICA ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET, BY PROCEDURE, 2019-2028 (USD MILLION)
TABLE 25 NORTH AMERICA CARDIOVASCULAR IN ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 26 NORTH AMERICA NEUROLOGICAL IN ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 27 NORTH AMERICA HEARING IN ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 28 NORTH AMERICA OTHERS IN ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 29 NORTH AMERICA ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 30 NORTH AMERICA HOSPITALS IN ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 31 NORTH AMERICA AMBULATORY SURGICAL CENTERS IN ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 32 NORTH AMERICA SPECIALIZED CLINICS IN BREAST RECONSTRUCTION MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 33 NORTH AMERICA CLINICS IN ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 34 NORTH AMERICA ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET, BY COUNTRY, 2019-2028 (USD MILLION)
TABLE 35 NORTH AMERICA ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET, BY PRODUCT, 2019-2028 (USD MILLION)
TABLE 36 NORTH AMERICA IMPLANTABLE CARDIOVERTER DEFIBRILLATORS IN ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET, BY PRODUCT, 2019-2028 (USD MILLION)
TABLE 37 NORTH AMERICA TRANS VENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS IN ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET, BY PRODUCT, 2019-2028 (USD MILLION)
TABLE 38 NORTH AMERICA IMPLANTABLE CARDIAC PACEMAKERS IN ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET, BY PRODUCT, 2019-2028 (USD MILLION)
TABLE 39 NORTH AMERICA NEURO STIMULATORS IN ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET, BY PRODUCT, 2019-2028 (USD MILLION)
TABLE 40 NORTH AMERICA IMPLANTABLE ACCESSORIES IN ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET, BY PRODUCT, 2019-2028 (USD MILLION)
TABLE 41 NORTH AMERICA ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET, BY SURGERY TYPE, 2019-2028 (USD MILLION)
TABLE 42 NORTH AMERICA ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET, BY PROCEDURE, 2019-2028 (USD MILLION)
TABLE 43 NORTH AMERICA ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 44 U.S. ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET, BY PRODUCT, 2019-2028 (USD MILLION)
TABLE 45 U.S. IMPLANTABLE CARDIOVERTER DEFIBRILLATORS IN ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET, BY PRODUCT, 2019-2028 (USD MILLION)
TABLE 46 U.S. TRANS VENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS IN ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET, BY PRODUCT, 2019-2028 (USD MILLION)
TABLE 47 U.S. IMPLANTABLE CARDIAC PACEMAKERS IN ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET, BY PRODUCT, 2019-2028 (USD MILLION)
TABLE 48 U.S. NEURO STIMULATORS IN ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET, BY PRODUCT, 2019-2028 (USD MILLION)
TABLE 49 U.S. IMPLANTABLE ACCESSORIES IN ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET, BY PRODUCT, 2019-2028 (USD MILLION)
TABLE 50 U.S. ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET, BY SURGERY TYPE, 2019-2028 (USD MILLION)
TABLE 51 U.S. ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET, BY PROCEDURE, 2019-2028 (USD MILLION)
TABLE 52 U.S. ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 53 CANADA ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET, BY PRODUCT, 2019-2028 (USD MILLION)
TABLE 54 CANADA IMPLANTABLE CARDIOVERTER DEFIBRILLATORS IN ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET, BY PRODUCT, 2019-2028 (USD MILLION)
TABLE 55 CANADA TRANS VENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS IN ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET, BY PRODUCT, 2019-2028 (USD MILLION)
TABLE 56 CANADA IMPLANTABLE CARDIAC PACEMAKERS IN ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET, BY PRODUCT, 2019-2028 (USD MILLION)
TABLE 57 CANADA NEURO STIMULATORS IN ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET, BY PRODUCT, 2019-2028 (USD MILLION)
TABLE 58 CANADA IMPLANTABLE ACCESSORIES IN ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET, BY PRODUCT, 2019-2028 (USD MILLION)
TABLE 59 CANADA ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET, BY SURGERY TYPE, 2019-2028 (USD MILLION)
TABLE 60 CANADA ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET, BY PROCEDURE, 2019-2028 (USD MILLION)
TABLE 61 CANADA ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 62 MEXICO ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET, BY PRODUCT, 2019-2028 (USD MILLION)
TABLE 63 MEXICO IMPLANTABLE CARDIOVERTER DEFIBRILLATORS IN ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET, BY PRODUCT, 2019-2028 (USD MILLION)
TABLE 64 MEXICO TRANS VENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS IN ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET, BY PRODUCT, 2019-2028 (USD MILLION)
TABLE 65 MEXICO IMPLANTABLE CARDIAC PACEMAKERS IN ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET, BY PRODUCT, 2019-2028 (USD MILLION)
TABLE 66 MEXICO NEURO STIMULATORS IN ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET, BY PRODUCT, 2019-2028 (USD MILLION)
TABLE 67 MEXICO IMPLANTABLE ACCESSORIES IN ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET, BY PRODUCT, 2019-2028 (USD MILLION)
TABLE 68 MEXICO ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET, BY SURGERY TYPE, 2019-2028 (USD MILLION)
TABLE 69 MEXICO ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET, BY PROCEDURE, 2019-2028 (USD MILLION)
TABLE 70 MEXICO ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET, BY END USER, 2019-2028 (USD MILLION)
图片列表
FIGURE 1 NORTH AMERICA ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET: SEGMENTATION
FIGURE 2 NORTH AMERICA ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET: DATA TRIANGULATION
FIGURE 3 NORTH AMERICA ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET: DROC ANALYSIS
FIGURE 4 NORTH AMERICA ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET: NORTH AMERICA VS REGIONAL MARKET ANALYSIS
FIGURE 5 NORTH AMERICA ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET: COMPANY RESEARCH ANALYSIS
FIGURE 6 SURGERY TYPE LIFELINE CURVE
FIGURE 7 NORTH AMERICA ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET: INTERVIEW DEMOGRAPHICS
FIGURE 8 NORTH AMERICA ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET: DBMR MARKET POSITION GRID
FIGURE 9 NORTH AMERICA ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET: MARKET APPLICATION COVERAGE GRID
FIGURE 10 NORTH AMERICA ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET: VENDOR SHARE ANALYSIS
FIGURE 11 NORTH AMERICA ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET: SEGMENTATION
FIGURE 12 THE INCREASE IN DEMAND FOR ACTIVE MEDICAL IMPLANTABLE DEVICES EXPECTED TO DRIVE THE NORTH AMERICA ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET IN THE FORECAST PERIOD OF 2021 TO 2028
FIGURE 13 CARDIOVASCULAR SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE NORTH AMERICA ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET IN 2021 & 2028
FIGURE 14 NORTH AMERICA IS EXPECTED TO DOMINATE THE NORTH AMERICA ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET, AND ASIA-PACIFIC IS EXPECTED TO GROW WITH THE HIGHEST CAGR IN THE FORECAST PERIOD OF 2021 TO 2028
FIGURE 15 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF THE NORTH AMERICA ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET
FIGURE 16 AGING POPULATION IN THE WORLD (IN MILLION)
FIGURE 17 NORTH AMERICA ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET: BY PRODUCT, 2020
FIGURE 18 NORTH AMERICA ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET: BY PRODUCT, 2019-2028 (USD MILLION)
FIGURE 19 NORTH AMERICA ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET: BY PRODUCT, CAGR (2021-2028)
FIGURE 20 NORTH AMERICA ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET: BY PRODUCT, LIFELINE CURVE
FIGURE 21 NORTH AMERICA ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET: BY SURGERY TYPE, 2020
FIGURE 22 NORTH AMERICA ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET: BY SURGERY TYPE, 2019-2028 (USD MILLION)
FIGURE 23 NORTH AMERICA ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET: BY SURGERY TYPE, CAGR (2021-2028)
FIGURE 24 NORTH AMERICA ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET: BY SURGERY TYPE, LIFELINE CURVE
FIGURE 25 NORTH AMERICA ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET: BY PROCEDURE, 2020
FIGURE 26 NORTH AMERICA ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET: BY PROCEDURE, 2019-2028 (USD MILLION)
FIGURE 27 NORTH AMERICA ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET: BY PROCEDURE, CAGR (2021-2028)
FIGURE 28 NORTH AMERICA ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET: BY PROCEDURE, LIFELINE CURVE
FIGURE 29 NORTH AMERICA ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET: BY END USER, 2020
FIGURE 30 NORTH AMERICA ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET: BY END USER, 2019-2028 (USD MILLION)
FIGURE 31 NORTH AMERICA ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET: BY END USER, CAGR (2021-2028)
FIGURE 32 NORTH AMERICA ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET: BY END USER, LIFELINE CURVE
FIGURE 33 NORTH AMERICA ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET: SNAPSHOT (2020)
FIGURE 34 NORTH AMERICA ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET: BY COUNTRY (2020)
FIGURE 35 NORTH AMERICA ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET: BY COUNTRY (2021 & 2028)
FIGURE 36 NORTH AMERICA ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET: BY COUNTRY (2020 & 2028)
FIGURE 37 NORTH AMERICA ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET: BY PRODUCT (2021-2028)
FIGURE 38 NORTH AMERICA ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET: COMPANY SHARE 2020 (%)
研究方法
数据收集和基准年分析是使用具有大样本量的数据收集模块完成的。该阶段包括通过各种来源和策略获取市场信息或相关数据。它包括提前检查和规划从过去获得的所有数据。它同样包括检查不同信息源中出现的信息不一致。使用市场统计和连贯模型分析和估计市场数据。此外，市场份额分析和关键趋势分析是市场报告中的主要成功因素。要了解更多信息，请请求分析师致电或下拉您的询问。
DBMR 研究团队使用的关键研究方法是数据三角测量，其中包括数据挖掘、数据变量对市场影响的分析和主要（行业专家）验证。数据模型包括供应商定位网格、市场时间线分析、市场概览和指南、公司定位网格、专利分析、定价分析、公司市场份额分析、测量标准、全球与区域和供应商份额分析。要了解有关研究方法的更多信息，请向我们的行业专家咨询。
可定制
Data Bridge Market Research 是高级形成性研究领域的领导者。我们为向现有和新客户提供符合其目标的数据和分析而感到自豪。报告可定制，包括目标品牌的价格趋势分析、了解其他国家的市场（索取国家列表）、临床试验结果数据、文献综述、翻新市场和产品基础分析。目标竞争对手的市场分析可以从基于技术的分析到市场组合策略进行分析。我们可以按照您所需的格式和数据样式添加您需要的任意数量的竞争对手数据。我们的分析师团队还可以为您提供原始 Excel 文件数据透视表（事实手册）中的数据，或者可以帮助您根据报告中的数据集创建演示文稿。
